Connection
David Lynch to NF-E2-Related Factor 2
This is a "connection" page, showing publications David Lynch has written about NF-E2-Related Factor 2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.417 |
|
|
|
-
Profeta V, McIntyre K, Wells M, Park C, Lynch DR. Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia. Expert Opin Investig Drugs. 2023 Jan; 32(1):5-16.
Score: 0.213
-
Keita M, McIntyre K, Rodden LN, Schadt K, Lynch DR. Friedreich ataxia: clinical features and new developments. Neurodegener Dis Manag. 2022 10; 12(5):267-283.
Score: 0.204